ImmusanT
Biotechnology company developing diagnostics and therapeutics for the diagnosis and treatment of celiac disease.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD247—371m (Dealroom.co estimates Nov 2017.)
Cambridge Massachusetts (HQ)
Authorizing premium user...